VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spain
← catalyst calendarSponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Completed
Study type
Observational
Enrollment
232actual
Sites
14
Country
Spain
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-11-13 | actual | When the study began enrolling |
| Primary completion | 2025-05-20 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-05-20 | actual | The whole study's end, after follow-up |
| First posted | 2024-10-10 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Hyperkalaemia
Primary outcomes
what the primary-completion date above is the date OFTo describe the status of kalaemia in patients treated with SZC in the real-world setting at first visit after treatment initiation.
measured From May 2021 up to 3 months before the start of data collection
To describe the usual HK management after treatment initiation with SZC in the real-world setting.
measured From May 2021 up to 3 months before the start of data collection
Publications
- PMID 35371465 — reports results
- PMID 36503972 — reports results
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed